Key facts
- GLAZER CAPITAL, LLC filed SCHEDULE 13G for CHECKPOINT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (CKPT).
- Disclosed ownership: 6.4%.
- Date of event: 10 Mar 2025.
GLAZER CAPITAL, LLC - 10 Mar 2025 SCHEDULE 13G Report for CHECKPOINT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (CKPT)
- Filing Manager
- GLAZER CAPITAL, LLC
- Reporting Manager
- Glazer Capital, LLC
- Symbol
- CKPT
- Shares outstanding
- 48,159,938 shares
- Disclosed Ownership
- 3,087,052 shares
- Ownership
- 6.4%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Mar 2025, 16:08:49 UTC
- Date of event
- 10 Mar 2025
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Key filing fact
GLAZER CAPITAL, LLC disclosed 6.4% ownership in CHECKPOINT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (CKPT) on 10 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Mar 2025, 16:08.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Glazer Capital, LLC | 6.4% | 3,087,052 | 0 | 3,087,052 | Paul J. Glazer | Paul J. Glazer, Managing Member | |
| Paul J. Glazer | 6.4% | 3,087,052 | 0 | 3,087,052 | Paul J. Glazer | Paul J. Glazer |
CIK / CUSIP context first